GlassScriptPhysician profile
Samuel S Groves
NPI 1821035304
$2,905.69
in general payments reported to CMS, 2019-2025
15 companies · $609 in 2025
The $609 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $478 · 2020: $163 · 2021: $300 · 2022: $391 · 2023: $475 · 2024: $491 · 2025: $609.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,574.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,574.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $1,640.13 | 2019-2025 | Lifevest |
| Boston Scientific Corporation | $379.94 | 2019-2025 | Avvigo Guidance System, Wolverine Coronary Cutting Balloon, General - Balloon Catheters |
| Kestra Medical Technology Services, INC. | $219.65 | 2024-2025 | Assure Wcd |
| Cardinal Health 200 LLC | $217.39 | 2019-2020 | |
| Abiomed | $80.82 | 2023-2024 | Impella |
| Shockwave Medical, INC | $68.84 | 2021-2023 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Cordis US Corp. | $64.41 | 2022 | |
| Amgen INC. | $55.72 | 2021 | |
| Pfizer INC. | $53.42 | 2022-2023 | |
| Medtronic, INC. | $50.11 | 2022-2025 | Linq II |
| Janssen Pharmaceuticals, INC | $18.13 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $16.20 | 2022 | |
| Teleflex LLC | $15.66 | 2025 | Orsiro Mission |
| Cardiovascular Systems INC. | $13.06 | 2022 | |
| Zoll Circulation INC | $12.21 | 2023 | Therox Ds2 Console, Catheter, Downstream Cartridge |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Samuel Groves listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.